Advanced search
Add to list

Anti-CGRP monoclonal antibodies for the treatment of episodic migraine : an overview of available results and comparison with the currently used prophylactics

(2018) CEPHALALGIA. 38(suppl. 1). p.151-151
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Vandervorst, F. et al. “Anti-CGRP Monoclonal Antibodies for the Treatment of Episodic Migraine : an Overview of Available Results and Comparison with the Currently Used Prophylactics.” Cephalalgia. Vol. 38. 2018. 151–151. Print.
APA
Vandervorst, F., Van Deun, L., De Keyser, J., Paemeleire, K., & Versijpt, J. (2018). Anti-CGRP monoclonal antibodies for the treatment of episodic migraine : an overview of available results and comparison with the currently used prophylactics. CEPHALALGIA (Vol. 38, pp. 151–151). Presented at the 17th Biennial Migraine Trust international symposium (MTIS).
Chicago author-date
Vandervorst, F., Laura Van Deun, Jacques De Keyser, Koen Paemeleire, and Jan Versijpt. 2018. “Anti-CGRP Monoclonal Antibodies for the Treatment of Episodic Migraine : an Overview of Available Results and Comparison with the Currently Used Prophylactics.” In Cephalalgia, 38:151–151.
Chicago author-date (all authors)
Vandervorst, F., Laura Van Deun, Jacques De Keyser, Koen Paemeleire, and Jan Versijpt. 2018. “Anti-CGRP Monoclonal Antibodies for the Treatment of Episodic Migraine : an Overview of Available Results and Comparison with the Currently Used Prophylactics.” In Cephalalgia, 38:151–151.
Vancouver
1.
Vandervorst F, Van Deun L, De Keyser J, Paemeleire K, Versijpt J. Anti-CGRP monoclonal antibodies for the treatment of episodic migraine : an overview of available results and comparison with the currently used prophylactics. CEPHALALGIA. 2018. p. 151–151.
IEEE
[1]
F. Vandervorst, L. Van Deun, J. De Keyser, K. Paemeleire, and J. Versijpt, “Anti-CGRP monoclonal antibodies for the treatment of episodic migraine : an overview of available results and comparison with the currently used prophylactics,” in CEPHALALGIA, London, UK, 2018, vol. 38, no. suppl. 1, pp. 151–151.
@inproceedings{8598753,
  articleno    = {abstract MTIS2018-1},
  author       = {Vandervorst, F. and Van Deun, Laura and De Keyser, Jacques and Paemeleire, Koen and Versijpt, Jan},
  booktitle    = {CEPHALALGIA},
  issn         = {0333-1024},
  language     = {eng},
  location     = {London, UK},
  number       = {suppl. 1},
  pages        = {abstract MTIS2018-1:151--abstract MTIS2018-1:151},
  title        = {Anti-CGRP monoclonal antibodies for the treatment of episodic migraine : an overview of available results and comparison with the currently used prophylactics},
  volume       = {38},
  year         = {2018},
}

Web of Science
Times cited: